ASPG and acute lymphoblastic leukemia: After excluding five children with non-ALL and four children diagnosed with AAP after relapse of ALL, the EFS of all enrolled children who were re-exposed to asparaginase was not significantly higher than that in children who were not re-exposed (76.4% vs. 54.4%, respectively; log-rank p=0.084) (Figure 1).